Multifocal Bullous Fixed Drug Eruption

Authors

  • Carolina Oliveira Unidade de Saúde Familiar Sem Fronteiras. Agrupamento de Centros de Saúde Entre Douro e Vouga I Feira/Arouca. Santa Maria da Feira.
  • Maria Alexandra Rodrigues Serviço de Dermatologia. Centro Hospitalar e Universitário do Porto. Porto.
  • Glória Cunha Velho Unidade de Saúde Familiar Sem Fronteiras. Agrupamento de Centros de Saúde Entre Douro e Vouga I Feira/Arouca. Santa Maria da Feira. Serviço de Dermatologia. Centro Hospitalar e Universitário do Porto. Porto. Instituto de Ciências Biomédicas Abel Salazar. Porto.

DOI:

https://doi.org/10.20344/amp.16519

Keywords:

Drug Eruptions, Etoricoxib, Non-steroidal Anti-inflammatory Drugs, Skin Diseases

Abstract

N/a.

Downloads

Download data is not yet available.

References

Chugh S, Sarkar R, Garg VK, Singh A, Keisham C. Multifocal fixed drug eruption with COX-2 inhibitor celecoxib. Indian J Dermatol. 2013;58:142–4.

Carneiro-Leão L, Cernadas J. Bullous fixed drug eruption caused by etoricoxib confirmed by patch testing. J Allergy Clin Immunol Pract. 2019;7:1629-30.

Sousa AS, Cardoso JC, Gouveia MP, Gameiro AR, Teixeira VB, Gonçalo M. Fixed drug eruption by etoricoxib confirmed by patch test. An Bras Dermatol. 2016;91:652-4.

Antunes J, Prates S, Leiria-Pinto P. Fixed drug eruption due to etoricoxib - a case report. Allergol Immunopathol. 2013;42:623-4.

Gómez dela Fuente E, Pampín Franco A, Caro Gutiérrez D, López Estebaranz J. Exantema fijo medicamentoso por etoricoxib con tolerancia a celecoxib. Utilidad de las pruebas epicutáneas. Actas Dermosifiliogr. 2014;105:314-5.

Downloads

Published

2022-02-28

How to Cite

1.
Oliveira C, Rodrigues MA, Cunha Velho G. Multifocal Bullous Fixed Drug Eruption. Acta Med Port [Internet]. 2022 Feb. 28 [cited 2024 Nov. 21];36(5):361-2. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/16519

Issue

Vol. 36 No. 5 (2023): May

Section

Medical Image

License

Copyright (c) 2023 Acta Médica Portuguesa

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.

Crossref
Scopus
Google Scholar
Europe PMC